ABSTRACT The whole-genome sequence of Streptomyces sp. strain CBMAI 2042, an endophytic actinobacterium isolated from Citrus sinensis branches, is described. The strain has the ability to inhibit the growth of Xylella fastidiosa and other human pathogens. In silico analysis highlighted the presence of nonribosomal peptide and polyketide synthases, revealing promising antibiotic assembly lines.
open reading frame (ORF) predictor, operating in the ab initio mode (M. Samborskyy, unpublished data). The annotation results were edited using Artemis (8) . Rapid Annotations using Subsystems Technology (RAST) server annotation (9) allowed for the identification of 7,198 candidate protein-coding genes. Additionally, 17 transcription factor initiators and subsystems related to the biosynthesis of secondary metabolites, fatty acids, lipids, isoprenoids, and siderophores were identified. Analysis through the antiSMASH 3.0.1 (10, 11) standalone platform highlighted 35 biosynthetic gene clusters (BGC). The production of valinomycin (NRP), alpiniamide (PK-NRP), and indigoidine (NRP) was confirmed by metabolite profile evaluation and heterologous host reconstitution (12, R. Sigrist, L. Gonzaga de Oliveira, 23 August 2017, Brazilian patent application BR1020170130239). This whole-genome sequencing reveals that the genome of endophyte Streptomyces sp. strain CBMAI 2042 encodes a large reservoir that qualifies for further biotechnological studies.
Data availability. This whole-genome shotgun project has been deposited at DDBJ/ENA/GenBank under the accession number RCOL00000000, BioProject number PRJNA487706, BioSample number SAMN09908177, and SRA number PRJNA487706 (SRA runs SRR8038340 to SRR8038346). The version described in this paper is the first version, RCOL01000000. Streptomyces sp. strain CBMAI 2042 was deposited at the Brazilian Collection of Environmental and Industrial Microorganisms (CBMAI).
